Live Quote · NASDAQAKBAHealthcare· Biotechnology

Akebia Therapeutics, Inc.

$0.39▼ 8.71%($-0.04)
MKT CAP $107.04MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
70
Valuation
40
Profitability
100
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKBA research report →

Analyst Price Target
$1.00+159.4% vs. today

Range $1 – $1

Analyst RatingBuy
7 Buy4 Hold1 Sell

Price Chart

-73.44% · this period
$1.70$1.05$0.40Nov 19May 22Nov 19
52-Week Range2% of range
Low
$0.36
Current
$0.39
High
$1.73